Clinical Breast Cancer

Papers
(The H4-Index of Clinical Breast Cancer is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Letter to the Editor regarding the article “Effectiveness and Safety of Pyrotinib-Based Therapy in the Treatment of HER2-Positive Breast Cancer Patients with Brain Metastases: A Multicenter Real-World55
Table of Contents40
Tumor ki67 Impact on Survival in Male Breast Cancer Patients: A Systematic Review and Meta-Analysis36
Letter to the Editor of Clinical Breast Cancer, on “Time to Update Evidence-Based Guideline Recommendations About Concurrent Tamoxifen and Antidepressant Use? A Systematic Review,” Conducted by Michel36
Association of XPC rs2228001, ESR2 rs1256030, and rs4986938 Gene Polymorphisms With Breast Cancer Risk in Bangladeshi Women: A Case-Control Study36
High Ki-67 expression is associated with increased risk of distant recurrence in Oncotype Dx low risk breast cancer33
Microsurgery on Steroids: The Impact of Chronic Immunosuppressive Therapy on Outcomes Following Free Flap Breast Reconstruction33
Quality-Adjusted Survival with Ribociclib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women with HR±HER2− Advanced Breast Cancer in the MONALEESA-3 Trial32
Is Immediate Breast Reconstruction With a Latissimus Dorsi Myocutaneous Flap Safe for Starting Adjuvant Chemotherapy in Patients With Breast Cancer?31
Table of Contents29
Editorial Board28
Survivorship Navigation for Young Women With Early-Stage Breast Cancer26
Editorial Board25
Intraoperative Touch Imprint Cytology in Breast Cancer Patients After Neoadjuvant Chemotherapy24
Shoulder function and health outcomes in newly diagnosed breast cancer patients receiving surgery: a prospective study24
Corrigendum to “Prognostic and predictive impact of beta-2 adrenergic receptor expression in HER2-positive breast cancer” [Clin Breast Cancer 2020; 20:262–73.e7]24
SPON2 acts as a tumor promoter in HR-positive/HER2-negative breast cancer by regulating β-catenin signaling23
The Influence of Socioeconomic Status on Stage at Diagnosis and Survival in Young Breast Cancer Patients22
Development and Validation of Preoperative Ultrasound-Based Risk Scoring Systems for Predicting Axillary Lymph Node Metastasis in Breast Cancer: A Multicenter, Retrospective Study22
Comment on: Prognostic Ability of the Indication for Adjuvant Systemic Therapy Based on Preoperative Biopsy and the Surgical Excision Specimen in Cases of Small Breast Tumors (CONSCIENCE): A Retrospec22
Circ_0108942 Regulates the Progression of Breast Cancer by Regulating the MiR-1178-3p/TMED3 Axis21
0.16045308113098